Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Short-term Investments: 2022-2023

Historic Short-term Investments for OptimizeRx (OPRX) over the last 2 years, with Q3 2023 value amounting to $53.6 million.

  • OptimizeRx's Short-term Investments rose 4310.69% to $53.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $53.6 million, marking a year-over-year increase of 4310.69%. This contributed to the annual value of $55.9 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that OptimizeRx reported Short-term Investments of $53.6 million as of Q3 2023, which was up 4310.69% from $52.9 million recorded in Q2 2023.
  • In the past 5 years, OptimizeRx's Short-term Investments registered a high of $57.3 million during Q1 2023, and its lowest value of $37.5 million during Q3 2022.